You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Drugs

The drug library provides access to information on over 100 cancer drugs available for use in Canada.

Displaying Drugs List

9 Items
Other Name(s): Imbruvica® (Janssen)
Funding:
Exceptional Access Program
  • iBRUtinib - For patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), according to specific criteria.
  • iBRUtinib - For relapsed and refractory Mantle Cell Lymphoma, according to clinical criteria
Updated
Jan 2018
Other Name(s): Idamycin® (multiple brands available)
Aug 2016
Other Name(s): Zydelig (TM) (Gilead Sciences )
Funding:
Exceptional Access Program
  • idelalisib - For the treatment of relapsed chronic lymphocytic leukemia according to specific clinical criteria
Nov 2016
Other Name(s): Ifex® (multiple brands available)
Aug 2016
Other Name(s): Gleevec® (multiple brands available)
Funding:
Exceptional Access Program
  • iMAtinib - Metastatic Gastrointestinal Stromal Tumours, with specific criteria
  • iMAtinib - Adults with newly diagnosed Ph+ ALL, with specific criteria
  • iMAtinib - Adjuvant Gastrointestinal Stromal Tumours, with specific criteria
ODB - General Benefit (with Therapeutic Notes)
  • iMAtinib - For treatment of Ph+ CML in chronic phase, blast phase or accelerated phase, with specific criteria
Updated
Feb 2018
Other Name(s): Intron A® (Merck)
Funding:
New Drug Funding Program
  • Interferon - Melanoma
ODB Limited Use
  • interferon alfa-2b - For hairy cell leukemia and Kaposi's Sarcoma
Aug 2016
Other Name(s): Yervoy® (Bristol-Myers Squibb)
Funding:
New Drug Funding Program
  • Ipilimumab - Previously Untreated Advanced Unresectable Melanoma
  • Ipilimumab - Previously Treated Advanced Unresectable Melanoma
Nov 2017
Other Name(s): Camptosar® (multiple brands available)
Funding:
New Drug Funding Program
  • Irinotecan - First Line - Metastatic Colorectal Small Bowel or Appendiceal Cancer
  • Irinotecan - Second Line - Metastatic Colorectal Small Bowel or Appendiceal Cancer
Nov 2017
Other Name(s): Ninlaro™ (Takeda Canada Inc.)
Sep 2016